Co-Founder in Residence, Reversing fibrosis (CEO / Commercial Cofounder)

DSV is seeking ambitious individuals with a strong technical and commercial background to join their venture creation program and spin out a new fibrosis drug company. This role offers significant opportunities to work at the forefront of novel therapies, developing therapeutic approaches targeting inflammatory and myeloid reprogramming to reverse fibrotic diseases. The company is backed by General Inception and aims to commercialize a promising company in 4 years.

Requirements

• You are highly motivated by unsolved challenges in fibrotic disease.
• You have entrepreneurial spirit and mindset.
• You have clear strategic thinking.
• You have 15+ years drug development experience (or equivalent).
• Deep commercial and strategic expertise in therapeutic development.
• Strong networks in investor and industry relations.

Benefits

• Optimized, purpose-built tools and resources
• Extensive network of investors and advisors
• Shared operational and venture creation support
• Funded initial investment (currently £250k +)
• Funding for grant acquisition
• Support post-spinout